PharmaShots | Incisive News in 3 Shots

Subscribe Now

Ascentage

Ascentage Reports the US FDA’s Acceptance of IND Application for APG-5918 to Treat Solid Tumors and Hematologic Malignancies

Ascentage Reports the US FDA’s Acceptance of IND Application for APG-5918 to Treat Solid Tumors and Hematologic Malignancies

June 30, 2022

Ascentage Reports First Patient Dosing of Lisaftoclax (APG-2575) in P-II (APG2575CC201) Study for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Ascentage Reports First Patient Dosing of Lisaftoclax (APG-2575) in P-II (APG2575CC201) Study for Chronic Lymphocytic Leukemia/Sma...

March 15, 2022

Ascentage and Innovent’s Olverembatinib Receive NMPA’s Approval for the Treatment of Chronic Myeloid Leukemia

Ascentage and Innovent’s Olverembatinib Receive NMPA’s Approval for the Treatment of Chronic Myeloid Leukemia

December 1, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us